MEK inhibition impairs influenza B virus propagation without emergence of resistant variants

Stephan Ludwig1, Thorsten Wolff, Christina Ehrhardt

  • 1Robert-Koch Institut, D-13353 Berlin, Germany. stephan.ludwig@uni-duesseldorf.de

FEBS Letters
|March 12, 2004
PubMed

Insights

Influenza B virus infection relies on the Raf/MEK/ERK pathway for replication. Inhibiting this pathway with U0126 blocks viral spread and nuclear export, with no resistant strains emerging.

Area of Science:

  • Virology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Influenza viruses, particularly types A and B, pose a significant global health risk.
  • Understanding host-pathogen interactions is crucial for developing effective antiviral strategies.

Purpose of the Study:

  • To investigate the role of the Raf/MEK/ERK signaling cascade in influenza B virus replication.
  • To determine if targeting this pathway can inhibit viral propagation and assess the potential for resistance development.

Main Methods:

  • Utilized dominant-negative mutants of Raf and ERK.
  • Employed the MEK inhibitor U0126 to block the Raf/MEK/ERK pathway.
  • Assessed viral propagation and titers in response to pathway modulation.

Main Results:

  • Influenza B virus infection activates the Raf/MEK/ERK cascade, which is essential for efficient virus production.
  • Inhibition of MEK (using U0126) or expression of dominant-negative mutants significantly impaired viral propagation.
  • Selective activation of the pathway led to increased virus titers.
  • MEK inhibition was found to interfere with a specific viral nuclear export process.
  • Crucially, no resistant influenza virus variants emerged when treated with U0126, indicating limited adaptability to this host-directed therapy.

Conclusions:

  • The Raf/MEK/ERK signaling pathway is a critical host factor supporting influenza B virus replication.
  • Targeting this pathway, specifically MEK, represents a promising antiviral strategy with a low risk of resistance.
  • This host-directed approach highlights the potential for developing novel therapeutics against influenza viruses.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...